Cargando…

Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report

Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare malignant hepatic cancer with characteristics that differ from those of typical hepatocellular carcinoma (HCC). Unlike conventional HCC, FLHCC is common in young patients without any underlying liver disease and is known to be associated with...

Descripción completa

Detalles Bibliográficos
Autor principal: Na, Seong Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Liver Cancer Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035731/
https://www.ncbi.nlm.nih.gov/pubmed/37383417
http://dx.doi.org/10.17998/jlc.2022.06.10
Descripción
Sumario:Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare malignant hepatic cancer with characteristics that differ from those of typical hepatocellular carcinoma (HCC). Unlike conventional HCC, FLHCC is common in young patients without any underlying liver disease and is known to be associated with a unique gene mutation. This cancer type is rare in Asia, with only a few cases being reported in Korea. We report a case of FLHCC in a young woman that successfully underwent surgical resection. The efficacy of alternative treatments, such as transarterial chemoembolization or systemic chemotherapies, has not yet been established. To conclude, early diagnosis and appropriate surgical resection are important for the treatment of FLHCC.